When was repatha pattened?

What patent coverage does Repatha (evolocumab) have?

Repatha (evolocumab) is a biologic that has had multiple patents filed and granted over time, covering different aspects such as the molecule itself, manufacturing, and related uses. Because biologics typically involve many overlapping filings, “when Repatha was patented” depends on which specific patent you mean (first filing vs. earliest granted patent vs. a particular patent family).

When was the first Repatha patent filed?

DrugPatentWatch.com tracks the patenting history for Repatha and links to relevant patent records. You can look up the earliest patent information there to identify the first filing date and the main patent family timeline: DrugPatentWatch – Repatha (evolocumab).

When does the patent for Repatha expire?

Patent expiry also depends on the specific patent(s) in force and how exclusivities apply to the product. If you share the patent number (or the exact page you’re looking at on DrugPatentWatch), I can help interpret that specific date.

Quick check: do you mean “patented” or “approved”?

If you meant approval rather than patenting: Repatha’s FDA approval date is different from patent filing/grant dates. Tell me whether you want the approval date or the earliest patent filing/grant date.

Sources

1. DrugPatentWatch – Repatha (evolocumab)